Cosmic CRF (543928)
CyclicalFairStock Score: 32/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,885 |
| Market Cap | ₹1,545.32 Cr |
| P/E Ratio | 27.22 |
| ROCE | 0% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 89.92% |
| Debt/Equity | — |
| Sales Growth | 79.74% |
| 52-Week Range | ₹550 — ₹1,885 |
| Sector | Industrial Products |
Strengths
- Latest quarter sales of ₹304 Cr and net profit of ₹25 Cr demonstrate strong recent execution and an 8.2% net margin.
- Sales growth of 79.74% and profit growth of 89.92% show exceptional momentum; PEG of 0.32 suggests the market is not pricing in full growth if it persists.
- Piotroski F-Score of 6/9 points to reasonably healthy fundamentals across profitability, leverage and operating efficiency.
Concerns
- P/E of 27.22 with zero dividend yield means the investor relies entirely on future growth and gets no income cushion.
- Iron & steel products is cyclical; current high growth could reflect peak-cycle earnings rather than durable compounding.
- Critical data missing: book value, ROE, debt/equity and promoter holding, so leverage and governance cannot be evaluated; reported ROCE of 0.00% needs explanation.
- Stock sits at ₹1,885, the top of the ₹550–₹1,885 52-week range, with FairStock Score of 32/100 labelled risky.
AI Analysis
At ₹1,885, Cosmic CRF sits at the very top of its 52-week range, up from ₹550. The market cap is ₹1,545 crore, and at a P/E of 27.22 I am paying a full price for today's earnings. Graham taught me that price is what you pay, but value is what you get; right now I cannot estimate value with confidence. The latest quarter does look strong: sales of ₹304 crore and net profit of ₹25 crore give an 8.2% margin. Trailing sales growth of 79.74% and profit growth of 89.92% are eye-catching, and a PEG of 0.32 would look attractive if such growth were durable. But this is iron and steel products, a cyclical industry. High growth and fat margins often appear near the top of the cycle, not at the beginning of a long compounder. Piotroski's F-Score of 6/9 gives some comfort on fundamentals, but I cannot assess leverage or promoter alignment because book value, ROE, debt/equity and promoter holding are all unavailable. The reported ROCE of 0.00% is a red flag that needs explanation. There is no dividend, so every rupee of return must come from price appreciation, which leaves no margin of safety at the 52-week high. FairStock Score of 32/100 labels it risky. I would need several more quarters of steady performance, full balance-sheet details, and evidence of pricing power before I could call this an investment. Today it looks like a fast grower in a cyclical sector, not the classic Graham bargain I search for.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer